Cardiovascular Devices Market Size, Share, Challenges and Growth Analysis Report 2034 The Cardiovascular Devices market is predicted to develop at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2034, when it is projected to reach USD 112.95 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 64.88 Billion in 2024. https://wemarketresearch.com/reports/cardiovascular-devices-market/361

The global prefilled syringes market size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor fueling the prefilled syringe market growth. According to the World Health Organization (WHO), 9 million deaths are caused by cancer worldwide every year. In total, NCDs cause close to 41 million deaths, or 71% of the global deaths, annually, states the WHO. visit: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946 The National Cancer Institute estimates that in the US alone, 1,735,530 new cancer cases were reported in 2018; by 2030, this figure is anticipated to reach 23.6 million. Such widespread prevalence of cancer and other NCDs has generated the need for alternative solutions such as biological drugs. The administration of these drugs requires modern devices such as prefilled syringes, which is foreseen to augment the prefilled syringes market potential in the forthcoming years. Fortune Business Insights™ provides the above information in its new report, titled “Prefilled Syringes Market Size, Share & Industry Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories) By Design (Double-chamber, Multiple-chamber, and Single-chamber) By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others) and Regional Forecast, 2019-2026”. The report states that the value of this market stood at USD 4.31 billion in 2018 and also shares the following information: Europe to Lead the Pack; Asia-Pacific to Grow at a Remarkable Pace Among regions, Europe is slated to dominate the prefilled syringes market share during the forecast period, with the region’s market size having stood at USD 1.76 billion in 2018. Factors propelling the market in Europe include growing uptake of self-injectable drug devices and increasing preference for biological drugs for treating chronic diseases. Product Diversification to be the Focus Area for Competitors Key players are putting in place different measures to gain a competitive edge, according to the prefilled syringes market analysis. While some companies are looking for ways to widen their product offerings, other participants are engaging in merger and acquisition activities to expand their presence in the market. More Trending Topics from Fortune Business Insights: https://www.fortunebusinessinsights.com/digital-pcr-market-102014 https://www.fortunebusinessinsights.com/nicotine-replacement-therapy-nrt-market-103362 https://www.fortunebusinessinsights.com/cardiovascular-devices-market-102418